Cite
HARVARD Citation
Lim, J. et al. (2022). A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection. Open forum infectious diseases. p. . [Online].